GlassScriptPhysician profile
Joseph Giaimo
NPI 1851788251
$2,608.68
in general payments reported to CMS, 2019-2025
14 companies · $288 in 2025
The $288 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $703 · 2023: $1,205 · 2024: $413 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,906.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,905.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,059.27 | 2023-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Propaten Vascular Graft |
| Angiodynamics, INC. | $450.31 | 2022-2023 | Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $360.97 | 2022-2023 | In.Pact Admiral |
| Inari Medical, INC. | $207.21 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Philips North America LLC | $124.58 | 2023-2024 | (Az7) Lasers |
| Cardiovascular Systems INC. | $77.75 | 2022 | |
| Silk Road Medical, INC. | $73.57 | 2022-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Boston Scientific Corporation | $48.26 | 2025 | Farapulse |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $46.29 | 2025 | Lifevest |
| Imperative Care, INC | $41.68 | 2024-2025 | Symphony Catheter, Prodigy Catheter |
| Terumo Medical Corporation | $41.39 | 2022-2024 | Metacross Otw |
| Amgen INC. | $32.41 | 2024-2025 | Repatha, Repatha |
| Biosense Webster, INC. | $29.36 | 2025 | Carto 3 |
| Astrazeneca Pharmaceuticals LP | $15.63 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Giaimo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.